| Literature DB >> 16545137 |
Emran M Razzaghi1, Afarin Rahimia Movaghar, Traci Craig Green, Kaveh Khoshnood.
Abstract
BACKGROUND: In Iran, there are an estimated 200,000 injecting drug users (IDUs). Injecting drug use is a relatively new phenomenon for this country, where opium smoking was the predominant form of drug use for hundreds of years. As in many countries experiencing a rise in injecting drug use, HIV/AIDS in Iran is associated with the injection of drugs, accounting for transmission of more than two-thirds of HIV infections. This study aimed to: describe the range of characteristics of IDUs in Tehran, Iran's capital city; 2) examine the injecting-related HIV risk behaviors of IDUs, and 3) suggest necessary interventions to prevent HIV transmission among IDUs and their families and sex partners.Entities:
Year: 2006 PMID: 16545137 PMCID: PMC1431517 DOI: 10.1186/1477-7517-3-12
Source DB: PubMed Journal: Harm Reduct J ISSN: 1477-7517
Number of interviewed individuals at each district
| District name | No. of Key Informant Interviews on the general district situation, the extent of drug use and risk behaviors | No. of participants and FGDs* with IDUs on attitudes of IDUs towards risk behaviors, related factors and potential interventions | No. of participants and FGDs with IDUs on the extent of drug use and risk behaviors | No. of In-depth interviews with IDUs on their own drug use pattern, trends, and risk behavior |
| Maghsud-Beik (M) | 13 | 0 | 0 | 0 |
| Amiriye (A) | 14 | 10 (1 FGD) | 16 (2 FGDs) | 8 |
| 13th Aban (S) | 13 | 11 (1 FGD) | 17 (2 FGDs) | 13 |
| Bagh-e-Azari (B) | 14 | 7 (1 FGD) | 21 (2 FGDs) | 14 |
| Vali-e-Asr (V) | 14 | 10 (1 FGD) | 25 (3 FGDs) | 10 |
| Audlajan (O) | 13 | 8 (1 FGD) | 23 (3 FGDs) | 14 |
| Total** | 81 | 46 (5 FGDs) | 102 (12 FGDs) | 59 |
* FGDs = Focus Group Discussions
** Some IDUs have participated in both FGDs and in-depth interviews.
Profiles of injecting drug users, their injecting risk behaviors*.
| Primary districts representing the profile | A | S, B | V, O |
| Relative size † | Majority | minority | minority |
| Unstable -------------------------------------------------------- Stable | |||
| Distinguishing characteristics | Predominantly male, live at home with family, stable resources (shelter, food, income from family), | Predominantly young males, live at home with family but inject in public places or 'secure houses', limited resources (unemployed, dependent on family/ friends, some criminal involvement), shared injections for economic and emotional support, prevention of overdose | Predominantly young males, live and inject in public places, poor health & hygiene, very limited/no resources (unemployed, criminal involvement common), multiple social problems (divorce, poverty, familial conflict); the most extreme of this group were the 'end-stage users' |
| HIV & injecting risk continuum | Higher risk ---------------------------------------------------- Lower risk | ||
| Boiling, direct heating of point | Licking point, rinsing with water, flushing with boiling water, wiping with cloth or paper; repeated reuse of syringes; injecting practices involving repeated injection of blood ("blood play") | Licking point, rinsing with water, wiping with cloth or paper, or none; repeated reuse of syringes; injecting practices involving repeated injection of blood ("blood play"); often inject alone | |
| Few syringe sharing occasions; frequent other equipment sharing | Many sharing occasions; sharing of other equipment typical | Primarily syringe sharing occasions; primarily sharing of other equipment | |
| Access to harm reduction materials #38; risk awareness | access to pharmacy-sold syringes | limited access to pharmacy-sold syringes; aware of HIV and injecting risks but continue to share | limited access to pharmacy-sold syringes and lack of awareness of risk drives sharing behaviors |
*Note, Maghsud-Beik district was not noted for its injecting drug use and thus does not appear as a primary district for any of the IDU profiles.
A = Amiriye, S = 13Aban, B = Bagh-e-Azari, V = Vali-e-Asr, O = Audlajan
† Relative size was determined through the key informant interviews and secondary data sources for all districts (e.g., admissions to drug treatment, overdose deaths, etc.)
Typology-targeted interventions
| Suggested interventions | Syringe and injecting hygiene awareness and training; improve access to pharmacy-sold syringes | Social support, training, increased access to low-threshold methadone maintenance treatment, syringe exchange programs, improve access to pharmacy-sold syringes; safer injection facilities | Mass syringe distribution and recollections, outreach, low threshold services (counseling, social support); safer injection facilities |